Francis Arickx

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries

Thomas Morel, Francis Arickx, Gustaf Befrits et al. · Orphanet Journal of Rare Diseases · 2013 · 123 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +14

Pharmaceutical regulation in 15 European countries review.

Francis Arickx, Irina Cleemput, Guillaume Dedet et al. · PubMed · 2016 · 105 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

The European challenges of funding orphan medicinal products

Márta Szegedi, Tamás Zelei, Francis Arickx et al. · Orphanet Journal of Rare Diseases · 2018 · 63 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +17

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno et al. · Frontiers in Pharmacology · 2016 · 55 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16

Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework

Aris Angelis, Mark Linch, Gilberto Montibeller et al. · Social Science & Medicine · 2019 · 45 citations · Full text

Business, Decision Sciences, Oncology +13